Clinical Trials Browser

Phase 2/3 × Interventional × Ototoxicity × Clear all

NCT00477607 2014-03-07

Alpha-Lipoic Acid in Preventing Hearing Loss in Cancer Patients Undergoing Treatment With Cisplatin

Phase 2/3 Completed

39 enrolled 11 charts

Ototoxicity